Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Zocor, Zoloft And Pravachol Will Be Key Generic Switches For Medco In ’06

Executive Summary

Medco sees a significant opportunity for growth in 2006 generic switches, Group President-National Accounts Timothy Wentworth says
Advertisement

Related Content

Teva/Ivax Merger Will Create Significant Pricing Flexibility In Generics
Teva/Ivax Merger Will Create Significant Pricing Flexibility In Generics
PBMs Eye Acquisitions In “Target-Rich Environment”
Generic Price War Remains Strong; Intensity Is Product Specific, Firms Say
Medco Prosecution Will Continue Under False Claims Act, Kickback Laws
Bristol Prepares For Life After Pravachol: Support Will Continue Into 2005
Pfizer Zoloft “Authorized” Generic Will Be Available From Ivax By Mid-2006
Merck Looks Past Medicare: Next Up, Covering The Uninsured
Merck Looks Past Medicare: Next Up, Covering The Uninsured

Topics

Advertisement
UsernamePublicRestriction

Register

PS045079

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel